Cargando…

Thrombomodulin (TM), thrombin-antithrombin complex (TAT), plasmin-α2-plasmininhibitor complex (PIC), and tissue plasminogen activator-inhibitor complex (t-PAIC) assessment of fibrinolytic activity in postpartum hemorrhage: a retrospective comparative cohort study

BACKGROUND: Detecting the changes of coagulation function in the early stage of postpartum hemorrhage (PPH), which is the leading cause of maternal death, is the key to treatment this serious disease, however, there is less effective assessment methods. Thrombomodulin (TM), thrombin-antithrombin com...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lele, Zhong, Junmin, Xiao, Du, Huang, Wei, Zheng, Zheng, Jiang, Yanmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816829/
https://www.ncbi.nlm.nih.gov/pubmed/36618792
http://dx.doi.org/10.21037/atm-22-5221
_version_ 1784864627195117568
author Wang, Lele
Zhong, Junmin
Xiao, Du
Huang, Wei
Zheng, Zheng
Jiang, Yanmin
author_facet Wang, Lele
Zhong, Junmin
Xiao, Du
Huang, Wei
Zheng, Zheng
Jiang, Yanmin
author_sort Wang, Lele
collection PubMed
description BACKGROUND: Detecting the changes of coagulation function in the early stage of postpartum hemorrhage (PPH), which is the leading cause of maternal death, is the key to treatment this serious disease, however, there is less effective assessment methods. Thrombomodulin (TM), thrombin-antithrombin complex (TAT), plasmin-α2-plasmininhibitor complex (PIC), and tissue plasminogen activator-inhibitor complex (t-PAIC) are the new direct indicators for coagulation and fibrinolysis, and considered sensitive molecular markers of the fibrinolytic system changing. The aim of this study was to investigate the changes of these 4 new indicators in the early stage of PPH. METHODS: We retrospectively reviewed the new coagulate indicators, TM, TAT, PIC, and t-PAIC, obtained from PPH patients at Guangzhou Women and Children’s Medical Center from January 2021 to July 2021. According to the amount of blood loss, the patients were divided into 3 groups: Mild group (blood loss <1,500 mL, n=17), Severe group (blood loss ≥1,500 mL, n=24); another 12 women who did not experience PPH were selected as the Normal group (n=12). The four indicators were measured at the time of PPH happened, or immediately when baby was born in the Normal group, and evaluated for the prediction of PPH. RESULTS: The t-PAIC level of the Severe group was significantly lower than the other 2 groups (Normal group vs. Mild group vs. Severe group: 13.9±2.0 vs. 9.4±1.8 vs. 7.5±0.9, P=0.020), and the PIC level was the highest (Normal group vs. Mild group vs. Severe group: 1.1±0.2 vs. 2.7±0.8 vs. 2.9±0.6, P=0.012). There was no significant difference in TM and TAT among the 3 groups. The odds ratio (OR) value of t-PAIC was 0.822, 95% confidence interval (CI): 0.697–0.970, P=0.020. The area under the curve (AUC) of PIC was 0.5, and t-PAIC was 0.775, the cut-off point was 6.295, the specificity was 75%, and the sensitivity was 75%. CONCLUSIONS: With the increasing of blood loss, t-PAIC decreased gradually, and is associated with severe PPH. This indicator may be a new predictor of PPH, and should be used in the early period of PPH for treatment.
format Online
Article
Text
id pubmed-9816829
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-98168292023-01-07 Thrombomodulin (TM), thrombin-antithrombin complex (TAT), plasmin-α2-plasmininhibitor complex (PIC), and tissue plasminogen activator-inhibitor complex (t-PAIC) assessment of fibrinolytic activity in postpartum hemorrhage: a retrospective comparative cohort study Wang, Lele Zhong, Junmin Xiao, Du Huang, Wei Zheng, Zheng Jiang, Yanmin Ann Transl Med Original Article BACKGROUND: Detecting the changes of coagulation function in the early stage of postpartum hemorrhage (PPH), which is the leading cause of maternal death, is the key to treatment this serious disease, however, there is less effective assessment methods. Thrombomodulin (TM), thrombin-antithrombin complex (TAT), plasmin-α2-plasmininhibitor complex (PIC), and tissue plasminogen activator-inhibitor complex (t-PAIC) are the new direct indicators for coagulation and fibrinolysis, and considered sensitive molecular markers of the fibrinolytic system changing. The aim of this study was to investigate the changes of these 4 new indicators in the early stage of PPH. METHODS: We retrospectively reviewed the new coagulate indicators, TM, TAT, PIC, and t-PAIC, obtained from PPH patients at Guangzhou Women and Children’s Medical Center from January 2021 to July 2021. According to the amount of blood loss, the patients were divided into 3 groups: Mild group (blood loss <1,500 mL, n=17), Severe group (blood loss ≥1,500 mL, n=24); another 12 women who did not experience PPH were selected as the Normal group (n=12). The four indicators were measured at the time of PPH happened, or immediately when baby was born in the Normal group, and evaluated for the prediction of PPH. RESULTS: The t-PAIC level of the Severe group was significantly lower than the other 2 groups (Normal group vs. Mild group vs. Severe group: 13.9±2.0 vs. 9.4±1.8 vs. 7.5±0.9, P=0.020), and the PIC level was the highest (Normal group vs. Mild group vs. Severe group: 1.1±0.2 vs. 2.7±0.8 vs. 2.9±0.6, P=0.012). There was no significant difference in TM and TAT among the 3 groups. The odds ratio (OR) value of t-PAIC was 0.822, 95% confidence interval (CI): 0.697–0.970, P=0.020. The area under the curve (AUC) of PIC was 0.5, and t-PAIC was 0.775, the cut-off point was 6.295, the specificity was 75%, and the sensitivity was 75%. CONCLUSIONS: With the increasing of blood loss, t-PAIC decreased gradually, and is associated with severe PPH. This indicator may be a new predictor of PPH, and should be used in the early period of PPH for treatment. AME Publishing Company 2022-12 /pmc/articles/PMC9816829/ /pubmed/36618792 http://dx.doi.org/10.21037/atm-22-5221 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Wang, Lele
Zhong, Junmin
Xiao, Du
Huang, Wei
Zheng, Zheng
Jiang, Yanmin
Thrombomodulin (TM), thrombin-antithrombin complex (TAT), plasmin-α2-plasmininhibitor complex (PIC), and tissue plasminogen activator-inhibitor complex (t-PAIC) assessment of fibrinolytic activity in postpartum hemorrhage: a retrospective comparative cohort study
title Thrombomodulin (TM), thrombin-antithrombin complex (TAT), plasmin-α2-plasmininhibitor complex (PIC), and tissue plasminogen activator-inhibitor complex (t-PAIC) assessment of fibrinolytic activity in postpartum hemorrhage: a retrospective comparative cohort study
title_full Thrombomodulin (TM), thrombin-antithrombin complex (TAT), plasmin-α2-plasmininhibitor complex (PIC), and tissue plasminogen activator-inhibitor complex (t-PAIC) assessment of fibrinolytic activity in postpartum hemorrhage: a retrospective comparative cohort study
title_fullStr Thrombomodulin (TM), thrombin-antithrombin complex (TAT), plasmin-α2-plasmininhibitor complex (PIC), and tissue plasminogen activator-inhibitor complex (t-PAIC) assessment of fibrinolytic activity in postpartum hemorrhage: a retrospective comparative cohort study
title_full_unstemmed Thrombomodulin (TM), thrombin-antithrombin complex (TAT), plasmin-α2-plasmininhibitor complex (PIC), and tissue plasminogen activator-inhibitor complex (t-PAIC) assessment of fibrinolytic activity in postpartum hemorrhage: a retrospective comparative cohort study
title_short Thrombomodulin (TM), thrombin-antithrombin complex (TAT), plasmin-α2-plasmininhibitor complex (PIC), and tissue plasminogen activator-inhibitor complex (t-PAIC) assessment of fibrinolytic activity in postpartum hemorrhage: a retrospective comparative cohort study
title_sort thrombomodulin (tm), thrombin-antithrombin complex (tat), plasmin-α2-plasmininhibitor complex (pic), and tissue plasminogen activator-inhibitor complex (t-paic) assessment of fibrinolytic activity in postpartum hemorrhage: a retrospective comparative cohort study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816829/
https://www.ncbi.nlm.nih.gov/pubmed/36618792
http://dx.doi.org/10.21037/atm-22-5221
work_keys_str_mv AT wanglele thrombomodulintmthrombinantithrombincomplextatplasmina2plasmininhibitorcomplexpicandtissueplasminogenactivatorinhibitorcomplextpaicassessmentoffibrinolyticactivityinpostpartumhemorrhagearetrospectivecomparativecohortstudy
AT zhongjunmin thrombomodulintmthrombinantithrombincomplextatplasmina2plasmininhibitorcomplexpicandtissueplasminogenactivatorinhibitorcomplextpaicassessmentoffibrinolyticactivityinpostpartumhemorrhagearetrospectivecomparativecohortstudy
AT xiaodu thrombomodulintmthrombinantithrombincomplextatplasmina2plasmininhibitorcomplexpicandtissueplasminogenactivatorinhibitorcomplextpaicassessmentoffibrinolyticactivityinpostpartumhemorrhagearetrospectivecomparativecohortstudy
AT huangwei thrombomodulintmthrombinantithrombincomplextatplasmina2plasmininhibitorcomplexpicandtissueplasminogenactivatorinhibitorcomplextpaicassessmentoffibrinolyticactivityinpostpartumhemorrhagearetrospectivecomparativecohortstudy
AT zhengzheng thrombomodulintmthrombinantithrombincomplextatplasmina2plasmininhibitorcomplexpicandtissueplasminogenactivatorinhibitorcomplextpaicassessmentoffibrinolyticactivityinpostpartumhemorrhagearetrospectivecomparativecohortstudy
AT jiangyanmin thrombomodulintmthrombinantithrombincomplextatplasmina2plasmininhibitorcomplexpicandtissueplasminogenactivatorinhibitorcomplextpaicassessmentoffibrinolyticactivityinpostpartumhemorrhagearetrospectivecomparativecohortstudy